Health Invest Partners Ab Supernus Pharmaceuticals, Inc. Transaction History

Health Invest Partners Ab

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$26.37 - $34.22 $8.83 Million - $11.5 Million	-335,000 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$23.54 - $31.39 $4.59 Million - $6.12 Million	-195,000 Reduced 36.79%	335,000 $8.93 Million
Q2 2021 Aug 10, 2021	SELL	$26.72 - $33.19 $106,880 - $132,760	-4,000 Reduced 0.75%	530,000 $16.3 Million
Q1 2021 Apr 30, 2021	BUY	$24.15 - $31.45 $1.67 Million - $2.17 Million	69,000 Added 14.84%	534,000 $14 Million
Q4 2020 Feb 05, 2021	BUY	$17.7 - $25.81 $8.23 Million - $12 Million	465,000 New	465,000 $11.7 Million

263

59.5M

47.9K

13.1K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.86B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Health Invest Partners Ab, based on Form 13F filings with the SEC.

Stay updated on Health Invest Partners Ab with notifications on news.